AstraZeneca joins U.S. drug price freeze for rest of 2018

AstraZeneca joins U.S. drug price freeze for rest of 2018

Source: 
Reuters
snippet: 

AstraZeneca has joined other drugmakers in freezing prices in the United States for the rest of 2018, following criticism by U.S. President Donald Trump over the cost of medicine.